Tilray Brands (NASDAQ:TLRY) Trading Down 2.7% – Here’s Why

Tilray Brands, Inc. (NASDAQ:TLRY) shares fell 2.7% during trading on Friday . The company traded as low as $6.65 and last traded at $6.75. 8,470,793 shares were traded during mid-day trading, an increase of 88% from the average session volume of 4,503,807 shares. The stock had previously closed at $6.94.

Key Tilray Brands News

Here are the key news stories impacting Tilray Brands this week:

• Positive Sentiment: Federal rescheduling (Schedule I → III) materially improves the tax outlook for U.S. cannabis operators and has ignited a sector rally; while Tilray is more of a global/craft‑beverage play (so it’s a sympathy beneficiary), the policy shift is broadly bullish for cannabis investor sentiment. Read More.
• Positive Sentiment: Tilray issued statements positioning the company to accelerate U.S. medical expansion and highlight its branded beverage and wellness channels, providing a narrative for upside if regulatory access materializes. Read More.
• Positive Sentiment: Large, unusual call‑option buying suggests speculative bullish positioning that can amplify intraday rallies (and volatility). Read More.
• Positive Sentiment: At least one Wall Street analyst (Roth Capital) is bullish and has given Tilray a sizable upside scenario, which supports momentum-driven buying. Read More.
• Neutral Sentiment: CEO interviews and media coverage reinforce the company’s strategic narrative around U.S. opportunity, but management has not yet provided concrete new U.S. revenue or timeline guidance. Read More.
• Neutral Sentiment: Trading experienced a LULD/volatility pause during the intraday surge — a market mechanism reflecting fast moves rather than changing fundamentals. (No single article; referenced in market coverage.)
• Negative Sentiment: Insider selling: a company director sold 33,556 shares (disclosed Form 4), which traders flagged and may have contributed to profit-taking. Read More.
• Negative Sentiment: “Sell‑the‑news” reversal and dilution concerns: early gains after the Schedule III headline faded as traders took profits, and an April prospectus for an at‑the‑market offering (up to ~$180M) resurfaced dilution worries—pressuring the stock. Read More.
• Negative Sentiment: Intraday coverage noted rapid fade after the premarket surge — the pattern (jump then giveback) underscores that today’s move was driven more by policy headlines and momentum trading than by an immediate, company-level earnings or cash‑flow improvement for Tilray. Read More.

Analysts Set New Price Targets

A number of brokerages have recently commented on TLRY. ATB Cormark Capital Markets dropped their price target on Tilray Brands from $9.50 to $9.00 and set a “sector perform” rating on the stock in a research report on Thursday, April 2nd. Weiss Ratings reissued a “sell (d-)” rating on shares of Tilray Brands in a research report on Wednesday, January 21st. Wall Street Zen raised Tilray Brands from a “sell” rating to a “hold” rating in a research report on Saturday, March 21st. Roth Mkm raised Tilray Brands from a “neutral” rating to a “buy” rating and set a $10.00 price target on the stock in a research report on Thursday, April 2nd. Finally, TD Cowen lowered their price objective on Tilray Brands from $10.00 to $7.00 and set a “buy” rating on the stock in a research report on Monday, March 30th. Three equities research analysts have rated the stock with a Buy rating, four have assigned a Hold rating and one has given a Sell rating to the stock. Based on data from MarketBeat.com, Tilray Brands has a consensus rating of “Hold” and an average price target of $11.50.

Tilray Brands Price Performance

The firm has a market capitalization of $786.71 million, a P/E ratio of -0.49 and a beta of 2.00. The company has a debt-to-equity ratio of 0.19, a quick ratio of 1.66 and a current ratio of 2.79. The firm has a 50-day moving average of $7.03 and a 200-day moving average of $9.51.

Tilray Brands (NASDAQ:TLRY) last released its quarterly earnings data on Wednesday, April 1st. The company reported ($0.24) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.14) by ($0.10). The business had revenue of $206.73 million during the quarter, compared to the consensus estimate of $201.35 million. Tilray Brands had a negative net margin of 156.51% and a negative return on equity of 3.31%. During the same period last year, the company posted ($0.87) earnings per share. As a group, analysts predict that Tilray Brands, Inc. will post -0.55 EPS for the current year.

Insider Transactions at Tilray Brands

In related news, Director David G. Hopkinson sold 33,556 shares of the company’s stock in a transaction that occurred on Tuesday, April 21st. The stock was sold at an average price of $6.94, for a total value of $232,878.64. The transaction was disclosed in a legal filing with the SEC, which is available through the SEC website. Company insiders own 0.84% of the company’s stock.

Institutional Investors Weigh In On Tilray Brands

Hedge funds have recently added to or reduced their stakes in the stock. Tudor Investment Corp ET AL purchased a new stake in Tilray Brands during the 3rd quarter valued at $518,000. Optiver Holding B.V. raised its stake in Tilray Brands by 239.4% during the 3rd quarter. Optiver Holding B.V. now owns 224,049 shares of the company’s stock valued at $388,000 after buying an additional 158,041 shares during the last quarter. Cresset Asset Management LLC raised its stake in Tilray Brands by 72.1% during the 3rd quarter. Cresset Asset Management LLC now owns 501,989 shares of the company’s stock valued at $868,000 after buying an additional 210,267 shares during the last quarter. Caitong International Asset Management Co. Ltd raised its stake in Tilray Brands by 99,204,800.0% during the 3rd quarter. Caitong International Asset Management Co. Ltd now owns 992,049 shares of the company’s stock valued at $1,716,000 after buying an additional 992,048 shares during the last quarter. Finally, Zuckerman Investment Group LLC purchased a new stake in Tilray Brands during the 3rd quarter valued at $147,000. 9.35% of the stock is currently owned by hedge funds and other institutional investors.

Tilray Brands Company Profile

Tilray Brands, Inc is a global cannabis-lifestyle and consumer packaged goods company engaged in the cultivation, production, distribution and sale of cannabis and cannabinoid-based products. The company develops and markets a diverse portfolio of branded products spanning medical cannabis, adult-use recreational products and wellness offerings. Through state-of-the-art cultivation facilities, research and development efforts, and quality control systems, Tilray Brands aims to deliver consistent, scalable products for a range of patient and consumer needs.

Tilray’s product lineup includes cannabis flower, pre-rolls, oils and tinctures, vapes, edibles and topicals, as well as hemp-derived cannabidiol (CBD) products.